Half of the people in the Netherlands with a psychotic disorder and metabolic problems such as serious hypertension or raised cholesterol levels are not receiving adequate treatment. The antipsychotic drugs they take can increase their risk of developing a metabolic disorder. The guidelines are not adhered to adequately, as health professionals are often unaware of the higher risk run by psychotic patients. These are the findings of a study carried out by psychologist Jojanneke Bruins at the UMCG. An article about her research has been published in the Journal of Clinical Psychiatry of 11 April.
For her research, Bruins monitored 1,259 patients with a psychotic disorder. They all underwent a series of three ROM screenings (an annual screening for psychiatric patients). Antipsychotic drugs are known to increase the risk of metabolic problems. In her research, Bruins studied the level of treatment these patients received for their metabolic disorders. She concentrated on high blood pressure, diabetes and raised lipid levels. It is the first time that patients from this group have been monitored for such a long time.
Bruins’ research showed that over half of the psychotic patients in her group had a metabolic disorder. After three ROM screenings, half of the patients suffering from metabolic disorders had still not been treated, even if the first screening had revealed a heightened risk. This was true of patients with a slightly higher risk as well as those with serious hypertension or high cholesterol levels. Young patients in particular received insufficient treatment for their metabolic disorder.
International guidelines for treating metabolic risk factors are already in place. They contain criteria specifying the point at which a risk is deemed high enough to require treatment with drugs. Bruins concludes that the guidelines are not being complied with. According to her, this is because there is too little attention for, and awareness of, metabolic risks in psychiatry, and confusion about who is responsible for treating these problems if they arise. Bruins: ‘The guidelines state that in principle, the GP is responsible for treating metabolic disorders, including in psychiatric patients. This doesn’t seem to be clear to everyone and furthermore, patients still need to be referred to their GP by a psychiatric health professional.’ Bruins also suspects that psychiatrists and GPs are not always fully aware of the extra risk these patients run.
Bruins would like to improve integration of the results of the annual ROM screenings into day - to-day practice. She thinks that this would improve the standard of individual care and help patients to recover.
The article in the Journal of Clinical Psychiatry
Source: news release UMCG
An international group of over 100 researchers led by Professor Lude Franke of the UMCG has identified hundreds of ‘key genes’. These key genes provide insight into the development of diseases and offer leads for medicine development.
A multidisciplinary team of researchers from 11 different countries are starting a project on speeding up the development of vaccines. Researchers from the University of Groningen (UG) and the University Medical Center Groningen (UMCG) will study...
Prof. Marian Joëls has been awarded the ALBA-FKNE Diversity Prize 2021 for her contribution to advancing gender equality in brain research. The prize highlights a scientist or group that has made outstanding contributions to promoting diversity in...
The UG website uses functional and anonymous analytics cookies. Please answer the question of whether or not you want to accept other cookies (such as tracking cookies).
If no choice is made, only basic cookies will be stored. More information